Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07511179 · ClinicalTrials.gov registry record · NA

Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia

A NA study, sponsored by Johns Hopkins University.

Not yet
Registry status
NA
Development phase
10
Enrollment target

NCT07511179: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT07511179 is a NA study that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07511179, a NA study, has not yet begun recruiting, sponsored by Johns Hopkins University.

NOT YET RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This research study investigates the feasibility and efficacy of a personalized, closed-loop electroencephalogram-transcranial electrical stimulation (EEG-tES) intervention for individuals with Primary Progressive Aphasia (PPA), addressing the inconsistent results of generic brain stimulation protocols. By integrating artificial intelligence (AI)-derived insights with real-time data, the study aims to customize transcranial electrical stimulation (tES) parameters, including electrode placement, intensity, and frequency to target the specific brain regions responsible for abnormal signaling in each participant. Over the intervention period paired with computerized cognitive training, the project will evaluate improvements in learning, memory, and functional connectivity, while simultaneously identifying clinical and physiological predictors to determine the viability of transitioning this low-cost, non-invasive technology into a remotely supervised, home-based therapy setting. The study duration will be a total of 6-8 weeks.

Interventions

  • DEVICE Active tES
  • BEHAVIORAL Cognitive Interventions

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-06
Est. Completion 2026-08
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT07511179

The ClinicalTrials.gov registry entry for NCT07511179 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Active tES is the first listed.

NCT07511179 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07511179 about?

NCT07511179 is a clinical study titled "Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia". This research study investigates the feasibility and efficacy of a personalized, closed-loop electroencephalogram-transcranial electrical stimulation (EEG-tES) intervention for individuals with Primary Progressive Aphasia (PPA), addressing the inconsistent results of generic brain stimulation protoc...

What is the current status of trial NCT07511179?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-06. Estimated completion is 2026-08.

What interventions are being tested in trial NCT07511179?

The interventions under investigation include: Active tES (DEVICE), Cognitive Interventions (BEHAVIORAL).

Who is sponsoring clinical trial NCT07511179?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.